HBsAg, hepatitis B surface antigen; ALT, alanine aminotransferase; ULN, the upper limit of normal; TDF, tenofovir disoproxil fumarate; HBV, hepatitis B virus; anti-HBs, hepatitis B surface antibody.

For decades, many Americans with hepatitis C have struggled to get tested or died waiting for a cure that remained inaccessibly expensive within the nation’s fractured health care system. President ...

Ashwin Dhanda does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

Hepatitis C is widely known by name, but far less understood in reality. It's a condition that can exist quietly in the body for years, causing little to no outward sign that anything is wrong, which ...

Epclusa (sofosbuvir/velpatasvir) is a brand-name prescription medication. It’s approved by the Food and Drug Administration (FDA) to treat hepatitis C, which is an ...

A Stanford study shows that jail-based hepatitis C programs could cut new infections by nearly half among people who inject ...

Hepatitis C is the leading blood borne infection, and the number one cause of liver disease in the United States. The Center for Disease Control estimates that 2.7 million people in the US are ...

Hepatitis C is the most common chronic bloodborne illness in the United States. In 2016, at least 2.4 million U.S. people were living with hepatitis C. Mothers with hepatitis C transmit the virus to 4 ...

Despite an arsenal of drugs, many Americans are still unaware of their infections until it’s too late. A Biden initiative languishes without Congressional approval. By Ted Alcorn In the 10 years since ...

For a decade now, the world has had highly effective medications for hepatitis C infections. In the United States, they’ve mostly been sitting on the shelf, according to a new study. These drugs, ...